A Randomized, Double-Blind, Parallel-Group, Fixed-Dose, Clinical Trial of Quetiapine at 600 Versus 1200 mg/d for Patients With Treatment-Resistant Schizophrenia or Schizoaffective Disorder

Title
A Randomized, Double-Blind, Parallel-Group, Fixed-Dose, Clinical Trial of Quetiapine at 600 Versus 1200 mg/d for Patients With Treatment-Resistant Schizophrenia or Schizoaffective Disorder
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
Volume 31, Issue 2, Pages 160-168
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2011-02-23
DOI
10.1097/jcp.0b013e31820f4fe0

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now